Literature DB >> 11166797

Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis.

M Filippi1, M Bozzali, G Comi.   

Abstract

Although post-mortem studies have shown that lesions of multiple sclerosis (MS) can be detected in the basal ganglia, conventional T2-weighted magnetic resonance (MR) imaging is poorly sensitive for detecting such abnormalities. This study was performed to investigate whether magnetization transfer (MT) and diffusion tensor MR imaging are able to detect in vivo basal ganglia changes in patients with MS. After image coregistration, MT ratio (MTR) and mean diffusivity (&Dmacr;) maps were obtained and MTR and &Dmacr; values of the putamen, head of the caudatus and thalamus measured from 31 patients with clinically definite MS and 14 age- and sex-matched healthy volunteers using region of interest analysis. Although we found slightly decreased MTR and increased &Dmacr; in the basal ganglia from patients compared to controls, suggesting increased extra-cellular water and reduced amount of 'barriers' restricting water molecular motion in the basal ganglia of patients with MS, none of the differences was statistically significant. These data suggest that the more sophisticated MR probes of tissue disruption and cellular integrity are no more sensitive than current conventional imaging for detecting basal ganglia abnormalities in patients with MS.

Entities:  

Mesh:

Year:  2001        PMID: 11166797     DOI: 10.1016/s0022-510x(00)00471-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Imaging of CNS myelin by positron-emission tomography.

Authors:  Bruno Stankoff; Yanming Wang; Michel Bottlaender; Marie-Stephane Aigrot; Frederic Dolle; Chunying Wu; Douglas Feinstein; Guo-Feng Huang; Frank Semah; Chester A Mathis; William Klunk; Robert M Gould; Catherine Lubetzki; Bernard Zalc
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.

Authors:  C S Yu; F C Lin; K C Li; T Z Jiang; C Z Zhu; W Qin; H Sun; P Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.

Authors:  Michael Amann; Athina Papadopoulou; Michaela Andelova; Stefano Magon; Nicole Mueller-Lenke; Yvonne Naegelin; Christoph Stippich; Ernst Wilhelm Radue; Oliver Bieri; Ludwig Kappos; Till Sprenger
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

Review 4.  Diffusion imaging in multiple sclerosis: research and clinical implications.

Authors:  M Inglese; Maxim Bester
Journal:  NMR Biomed       Date:  2010-08       Impact factor: 4.044

5.  Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis.

Authors:  Amin Abolhasani Foroughi; Roohollah Salahi; Alireza Nikseresht; Hora Heidari; Masoume Nazeri; Ali Khorsand
Journal:  Neuroradiol J       Date:  2017-04-28

Review 6.  Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Elizabeth N York; Michael J Thrippleton; Rozanna Meijboom; David P J Hunt; Adam D Waldman
Journal:  Brain Commun       Date:  2022-04-04

7.  Magnetic resonance diffusion tensor imaging for occult lesion detection in multiple sclerosis.

Authors:  Jiafeng Chen; Chunkui Zhou; Lijun Zhu; Xiuli Yan; Yonghong Wang; Xin Chen; Shaokuan Fang
Journal:  Exp Ther Med       Date:  2016-12-02       Impact factor: 2.447

8.  Disruption of neurite morphology parallels MS progression.

Authors:  Barbara Spanò; Giovanni Giulietti; Valerio Pisani; Manuela Morreale; Elisa Tuzzi; Ugo Nocentini; Ada Francia; Carlo Caltagirone; Marco Bozzali; Mara Cercignani
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.